VARIATION IN THE DEFINITION OF CLINICAL TARGET VOLUMES FOR PELVIC NODAL CONFORMAL RADIATION THERAPY FOR PROSTATE CANCER

被引:48
作者
Lawton, Colleen A. F. [1 ]
Michalski, Jeff [2 ]
El-Naqa, Issam [3 ]
Kuban, Deborah [4 ]
Lee, W. Robert [5 ]
Rosenthal, Seth A. [6 ]
Zietman, Anthony [7 ]
Sandler, Howard [8 ]
Shipley, William [7 ]
Ritter, Mark [9 ]
Valicenti, Richard [10 ]
Catton, Charles [11 ]
Roach, Mack, III [12 ]
Pisansky, Thomas M. [13 ]
Seider, Michael [14 ]
机构
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[2] Washington Univ, St Louis, MO USA
[3] Mallinckrodt Inst Radiol, St Louis, MO USA
[4] MD Anderson, Houston, TX USA
[5] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
[6] Radiol Associates Sacramento, Radiat Oncol Ctr, Sacramento, CA USA
[7] Massachusetts Gen Hosp, Boston, MA 02114 USA
[8] Univ Michigan, Med Ctr, Ann Arbor, MI USA
[9] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
[10] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[11] Princess Margaret Hosp, Toronto, ON, Canada
[12] UCSF Comprehens Canc Ctr, San Francisco, CA USA
[13] Mayo Clin, Rochester, MN USA
[14] Akron City Hosp, Akron, OH USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2009年 / 74卷 / 02期
关键词
Prostate cancer; Pelvic lymph nodes; Target volume; EXTERNAL-BEAM RADIOTHERAPY; PHASE-III TRIAL; ANDROGEN SUPPRESSION; NEOADJUVANT; IRRADIATION; DEPRIVATION; ADJUVANT;
D O I
10.1016/j.ijrobp.2008.08.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Purpose: We conducted a comparative study of clinical target volume (CTV) definition of pelvic lymph nodes by multiple genitourinary (GU) radiation oncologists looking at the levels of discrepancies amongst this group. Methods and Materials: Pelvic computed tomography (CT) scans from 2 men were distributed to 14 Radiation Therapy Oncology Group GU radiation oncologists with instructions to define CTVs for the iliac and presacral lymph nodes. The CT data with contours were then returned for analysis. In addition, a questionnaire was completed that described the physicians' method for target volume definition. Results: Significant variation in the definition of the iliac and presacral CTVs was seen among the physicians. The minimum, maximum, mean (SD) iliac volumes (mL) were 81.8, 876.6, 337.6 +/- 203 for case 1 and 60.3, 627.7, 251.8 +/- 159.3 for case 2. The volume of 100% agreement was 30.6 and 17.4 for case 1 and 2 and the volume of the union of all contours was 1,012.0 and 807.4 forcase 1 and 2, respectively. The overall agreement was judged to be moderate in both cases (kappa = 0.53 (p < 0.0001) and kappa = 0.48 (p < 0.0001). There was no volume of 100% agreement for either of the two presacral volumes. These variations were confirmed in the responses to the associated questionnaire. Conclusions: Significant disagreement exists in the definition of the CTV for pelvic nodal radiation therapy among GU radiation oncology specialists. A consensus needs to be developed so as to accurately assess the merit and safety of such treatment. (C) 2009 Elsevier Inc.
引用
收藏
页码:377 / 382
页数:6
相关论文
共 12 条
[1]
[Anonymous], 0534 RTOG
[2]
[Anonymous], BIOMETRICS
[3]
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial [J].
Bolla, M ;
Collette, L ;
Blank, L ;
Warde, P ;
Dubois, JB ;
Mirimanoff, RO ;
Storme, G ;
Bernier, J ;
Kuten, A ;
Sternberg, C ;
Mattelaer, J ;
Torecilla, JL ;
Pfeffer, JR ;
Cutajar, CL ;
Zurlo, A ;
Pierart, M .
LANCET, 2002, 360 (9327) :103-108
[4]
Fleiss JL., 1981, STAT METHODS RATES P, V2
[5]
Ten-year follow-up of radiation therapy oncology group protocol 92-02: A phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer [J].
Horwitz, Eric M. ;
Bae, Kyounghwa ;
Hanks, Gerald E. ;
Porter, Arthur ;
Grignon, David J. ;
Brereton, Harmar D. ;
Venkatesan, Varagur ;
Lawton, Colleen A. ;
Rosenthal, Seth A. ;
Sandler, Howard M. ;
Shipley, William U. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15) :2497-2504
[6]
An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: Updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions [J].
Lawton, Colleen A. ;
DeSilvio, Michelle ;
Roach, Mack, III ;
Uhl, Valery ;
Kirsch, Robert ;
Seider, Michael ;
Rotman, Marvin ;
Jones, Christopher ;
Asbell, Sucha ;
Valicenti, Richard ;
Hahn, Stephen ;
Thomas, Charles R., Jr. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03) :646-655
[7]
Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma - Long-term results of Phase III RTOG 85-31 [J].
Pilepich, MV ;
Winter, K ;
Lawton, CA ;
Krisch, RE ;
Wolkov, HB ;
Movsas, B ;
Hug, EB ;
Asbell, SO ;
Grignon, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (05) :1285-1290
[8]
Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: Long-term results of RTOG 8610 [J].
Roach, Mack, III ;
Bae, Kyounghwa ;
Speight, Joycelyn ;
Wolkov, Harvey B. ;
Rubin, Phillip ;
Lee, R. Jeffrey ;
Lawton, Colleen ;
Valicenti, Richard ;
Grignon, David ;
Pilepich, Miljenko V. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) :585-591
[9]
Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial [J].
Roach, Mack, III ;
DeSilvio, Michelle ;
Valicenti, Richard ;
Grignon, David ;
Asbell, Sucha O. ;
Lawton, Colleen ;
Thomas, Charles R., Jr. ;
Shipley, William U. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03) :647-653
[10]
*RTOG, 0521 RTOG